Everolimus Can Overcome Trastuzumab Resistance In HER-2 Positive Early ... Big News Network.com breast cancers can develop to trastuzumab has left researchers contemplating a puzzle. The study showed a statistically non-significant benefit in clinical response rates for some patients with early breast cancer when everolimus was added to treatment ... |
